Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | CSF1R | P07333 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | KIT | P10721 | 1/20 | 0.37 |
| ▸ | FLT3 | P36888 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | CDC14B | O60729 | 1/20 | 0.36 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26168238 | 0.88 | KMT2A (0.37) | KMT2AMEN1CSF1RPDGFRBMAPT | |
| SCHEMBL26168222 | 0.82 | MAOA (0.39) | KMT2AMEN1MAPTLIMK1CA12 | |
| SCHEMBL26168258 | 0.76 | MEN1 (0.35) | KMT2AMEN1LIMK1CA12CA9 | |
| SCHEMBL26298519 | 0.73 | CA1 (0.42) | KMT2AMAPTCA1CA2DDR2 | |
| SCHEMBL26168244 | 0.73 | CA1 (0.42) | KMT2AMEN1CSF1RPDGFRBMAPT | |
| SCHEMBL26168121 | 0.70 | MAOA (0.40) | KMT2AMEN1MAPTCA12CA9 | |
| SCHEMBL26168253 | 0.70 | MEN1 (0.35) | KMT2AMEN1LIMK1CA12CA9 | |
| SCHEMBL26168224 | 0.68 | KDM4E (0.38) | KMT2AMEN1MAPTCA12CA9 | |
| SCHEMBL26168225 | 0.68 | MAOA (0.38) | KMT2AMEN1MAPTLIMK1CA12 | |
| SCHEMBL19011017 | 0.68 | CDC14B (0.52) | KMT2AMEN1CSF1RPDGFRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2023-08-31 | — | — | US | disclosed |
| US-11678565-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678565-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OPRD1 | KMT2A 4323/4885MEN1 3172/4885CSF1R 1542/4885 |
| US-20230276696-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, PORCN | KMT2A 4003/4885MEN1 3556/4885CSF1R 2260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.